Kerr W. Holbrook - 29 Apr 2021 Form 3 Insider Report for Avanos Medical, Inc. (AVNS)

Role
SVP, GM Chronic Care
Signature
/s/ Ross Mansbach, as attorney-in-fact for Kerr Holbrook
Issuer symbol
AVNS
Transactions as of
29 Apr 2021
Net transactions value
$0
Form type
3
Filing time
10 May 2021, 10:27:31 UTC
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVNS Common Stock 19,909 29 Apr 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVNS Common Stock 29 Apr 2021 Common Stock 5,919 $28.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options issued pursuant to the Avanos Medical, Inc. Equity Participation Plan. The award will vest 30% on May 7, 2021, 30% on May 7, 2022, and 40% on May 7, 2023, subject to earlier vesting in the event of death, disability or certain other events.